Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CN
$ 0.387
-10 %
$ 1.35 M
Market Cap
-0.11
P/E
INCOME STATEMENT
1.93 M
REVENUE
-2.52 M
OPERATING INCOME
-3.1 M
NET INCOME
EFFICIENCY
Earnings Waterfall
China SXT Pharmaceuticals, Inc.
| Revenue | 1.93 M |
| Cost Of Revenue | 1.37 M |
| Gross Profit | 554 K |
| Operating Expenses | 3.07 M |
| Operating Income | -2.52 M |
| Other Expenses | 583 K |
| Net Income | -3.1 M |
Income Statement
Millions
| Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 1.9 | 2.0 | 2.6 | 4.8 | 5.2 | 7.0 | 7.0 | 4.9 | 3.7 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 1.4 | 1.5 | 1.4 | 1.9 | 2.5 | 2.4 | 3.6 | 2.6 | 2.9 |
| Gross Profit | 0.6 | 0.4 | 1.3 | 2.8 | 2.7 | 4.6 | 3.4 | 2.3 | 0.8 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 3.1 | 6.0 | 6.4 | 5.0 | 4.0 | 2.8 | 1.8 | 0.7 | 0.6 |
| Selling, General and Administrative Expenses | 3.1 | 6.0 | 6.4 | 5.0 | 4.0 | 2.8 | 1.8 | 0.7 | 0.6 |
| Research and Development Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (2.5) | (5.6) | (5.2) | (2.2) | 4.3 | 1.8 | 1.6 | 1.6 | 0.2 |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0.5 | 0.5 | 0.2 | 1.6 | 3.3 | 5.17 K | 779 | 0 | 0 |
| Total Other Income | (0.6) | (0.3) | (0.2) | (0.7) | (9.0) | 22 K | 4.58 K | 22 K | 20.4 K |
| Pre-Tax Income | (3.1) | (5.9) | (5.4) | (2.9) | (10.4) | 1.8 | 1.6 | 1.6 | 0.2 |
| NET INCOME | |||||||||
| Tax Provision | 0 | 0.5 | 0.3 | (0.2) | (0.1) | 0.3 | 0.4 | 0.4 | 47.2 K |
| Net Income | (3.1) | (5.9) | (5.7) | (2.7) | (10.3) | 1.5 | 1.2 | 1.2 | 0.1 |
| EPS | 3.57 | 22.2 | 138 | 95.5 | 832 | 150 | 0 | 0 | 0 |